Phase 1

Enrolling
Colorectal Cancer, NSCLC, or Other Advanced Solid Tumors
LY3537982

The safety and efficacy of the agents under investigation have not been established. There is no guarantee that the agents will receive regulatory approval and become commercially available for the uses being investigated.